ZOMDF — Zomedica Balance Sheet
0.000.00%
- $52.92m
- -$18.44m
- $27.29m
- 56
- 55
- 21
- 40
Annual balance sheet for Zomedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 62 | 195 | 115 | 90.5 | 71.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.146 | 0.765 | 1.86 | 2.2 | 3.07 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 62.9 | 200 | 124 | 99.9 | 81.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.9 | 2.53 | 9.17 | 25.3 | 26.2 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 66.1 | 280 | 280 | 253 | 207 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.03 | 4.34 | 7.81 | 9.03 | 9.33 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.12 | 9.51 | 12.2 | 13.2 | 11.7 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 63 | 271 | 267 | 240 | 196 |
Total Liabilities & Shareholders' Equity | 66.1 | 280 | 280 | 253 | 207 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |